Trademark: 86352224
Word
INBAZOME
Status
Dead
Status Code
605
Status Date
Wednesday, August 19, 2015
Serial Number
86352224
Mark Type
4000
Filing Date
Wednesday, July 30, 2014
Published for Opposition
Tuesday, April 21, 2015
Abandoned Date
Wednesday, August 19, 2015

Trademark Owner History
Pfizer Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, smoking cessation preparations; vaccines for human use

Trademark Events
Aug 19, 2015
Abandonment Notice Mailed - After Publication
Aug 19, 2015
Abandonment - After Publication
Aug 14, 2015
Teas Express Abandonment Received
May 20, 2015
Extension Of Time To Oppose Received
Apr 21, 2015
Official Gazette Publication Confirmation E-Mailed
Apr 21, 2015
Published For Opposition
Apr 1, 2015
Notification Of Notice Of Publication E-Mailed
Mar 13, 2015
Law Office Publication Review Completed
Mar 12, 2015
Approved For Pub - Principal Register
Mar 4, 2015
Examiner's Amendment Entered
Mar 3, 2015
Assigned To Lie
Mar 3, 2015
Notification Of Examiners Amendment E-Mailed
Mar 3, 2015
Examiners Amendment E-Mailed
Mar 3, 2015
Examiners Amendment -Written
Oct 28, 2014
Notification Of Non-Final Action E-Mailed
Oct 28, 2014
Non-Final Action E-Mailed
Oct 28, 2014
Non-Final Action Written
Oct 21, 2014
Letter Of Protest Accepted
Sep 17, 2014
Notification Of Non-Final Action E-Mailed
Sep 17, 2014
Non-Final Action E-Mailed
Sep 17, 2014
Non-Final Action Written
Sep 17, 2014
Assigned To Examiner
Aug 7, 2014
New Application Office Supplied Data Entered In Tram
Aug 2, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24